Wednesday, July 28, 2021
9:00 AM
- 10:00 AM
Presenter: Chantal Mathieu, MD, PhD
Organization: University of Leuven
Dr. Chantal Mathieu is a physician-scientist who has contributed to the field of diabetes and endocrinology both on the basic and the clinical research side.
Her work in animal models of type 1 diabetes (T1D) has established 1,25-dihydroxyvitamin D3 as immune modulator and her demonstration of the potential of Lactococcus Lactis as carrier tool for peptides and proteins was the basis for a worldwide clinical trial in people with newly diagnosed T1D. Her research group was among the first to demonstrate the relevance of post-translational modifications of beta-cell peptides and proteins in autoantigen generation in murine and human T1D.
Her clinical work involving new products and treatment paradigms in diabetes, like new insulins, adjunct therapies in T1D and diagnosis of gestational diabetes, as well as her educational skills, have made her a prominent speaker in international fora. Finally, her organizational skills were instrumental in shaping diabetes care in Belgium, promoting shared-care, positioning of diabetes education and reimbursement of novel technologies. She is a co-author of several consensus papers, including the 2018-19 ADA/EASD Consensus on glucose lowering therapies in type 2 diabetes.
She leads the private-public partnership INNODIA sponsored through the EU’s Innovative Medicines Initiative (www.innodia.eu). This pan-European INNODIA project is a consortium of more than 40 academic and industry partner institutions and 50 satellite clinical recruitment centers on biomarker discovery and interventions targeting prevention and arrest of T1D. She has, from the beginning of the INNODIA project, put the people and families living with T1D at the center of the work, through the establishment of the Patient Advisory Committee.
Since 2018, she is (senior) vice-president of EASD (www.easd.org), chair of postgraduate education where she established an e-learning platform (www.easd-elearning.org) and since 2020 she chairs the European Diabetes Forum (www.eudf.org).
Register now